Old age and EGFR mutation status in inoperable early‐stage non‐small cell lung cancer patients receiving stereotactic ablative radiotherapy: A single institute experience of 71 patients in Taiwan

Old age and EGFR mutation status in inoperable early‐stage non‐small cell lung cancer patients receiving stereotactic ablative radiotherapy: A single institute experience of 71 patients in Taiwan

Abstract Background Stereotactic ablative radiotherapy (SABR) is now the standard of care for patients with inoperable early‐stage lung cancer. Many of these patients are elderly. EGFR (epidermal growth factor receptor) mutation is also common in the Asian population. Methods To evaluate the effects...

Full description

Bibliographic Details
Main Authors: Yuan‐Hung Wu, Yu‐Mei Kang, Yu‐Wen Hu, Keng‐Li Lan, Sang‐Hue Yen, Tzu‐Yu Lai, Tien‐Li Lan, Yuh‐Min Chen, Chao‐Hua Chiu, Yung‐Hung Luo, Heng‐sheng Chao, Chi‐Lu Chiang, Tsu‐Hui Shiao, Chao‐Neng Yang, Wen‐Hu Hsu, Yu‐Chung Wu, Han‐Shui Hsu, Jung‐Jyh Hung, Chien‐Sheng Huang, Po‐Kuei Hsu, Yi‐Wei Chen
Format: Article
Language:English
Published: Wiley 2023-03-01
Series:Thoracic Cancer
Subjects:
EGFR
lung cancer
old age
SABR
Online Access:https://doi.org/10.1111/1759-7714.14786

Internet

https://doi.org/10.1111/1759-7714.14786

Similar Items